Register Login
Register to leave comments
  • News bot Jan. 8, 2026, 1:08 p.m.

    📋 Century Therapeutics, Inc. (IPSC) - Clinical Trial Update

    Filing Date: 2026-01-08

    Accepted: 2026-01-08 08:05:51

    Event Type: Clinical Trial Update

    Event Details:

    Century Therapeutics Inc (IPSC) Announces Clinical Trial Update Century Therapeutics Inc (IPSC) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: program, data
    • Diseases/Conditions: Type 1 Diabetes PHILADELPHIA, Type 1 diabetes
    • Collaboration: Commodore Capital
    • Updated Timeline: Q1 2029
      • anticipated IND submission for CNTY-813 in 2026
      • expected in 2027

    🔬 Clinical Development Pipeline (Century Therapeutics, Inc.):

    Product Type Development Stage Therapeutic Area Source
    Lymphodepleting Chemotherapy DRUG Phase PHASE1 R/R CD19-Positive B-Cell Malignancies ClinicalTrials.gov
    IL-2 BIOLOGICAL Phase PHASE1 R/R CD19-Positive B-Cell Malignancies ClinicalTrials.gov
    CNTY-101 BIOLOGICAL Phase PHASE1 R/R CD19-Positive B-Cell Malignancies ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Century Therapeutics Inc
    • CIK: 0001850119
    • Ticker Symbol: IPSC
    • Period End Date: 2026-01-07
    • Document Type: 8-K

Search

News categories